Inamura Kentaro

イナムラケンタロウ | Inamura Kentaro

Affiliation and department：
Job title： Professor
Other affiliations (1)：

Homepage URL (2)： https://tpathol.com/ , https://en.tpathol.com/

Research field (3)： Tumor biology , Experimental pathology , Human pathology

Research theme for competitive and other funds (15)：

2023 - 2025 細菌と遺伝子発現の可視化による腫瘍内細菌が転移におよぼす影響の解明
2022 - 2025 Investigation for modulating effects of tumor microbiota on cancer therapeutics: Towards microbiome-modulating strategies against metastasizing cancer
2022 - 2023 抗がん薬物効果に影響する腫瘍内細菌とがん細菌ネットワークの解明~転移性がんの革新的細菌標的治療戦略に向けて
2021 - 2022 デジタル形態病理学とゲノム科学の融合による肺がん免疫微小環境ネットワークの特徴化と個別化免疫療法への展開
2019 - 2022 蛍光ナノイメージング法による肺癌免疫微小環境の特徴化: 個別化免疫療法を目指して

Show all

Papers (168)：

Yasuyuki Shigematsu, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Kentaro Inamura. Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma. Virchows Archiv. 2024
Yasuyuki Shigematsu, Rumiko Saito, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi, Kentaro Inamura. Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence. Cancers. 2024. 16. 17. 3003
Yasuyuki Shigematsu, Rumiko Saito, Gulanbar Amori, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi, Kentaro Inamura. Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis. Cancer science. 2024
Shu Kato, Yasuyuki Shigematsu, Rumiko Saito, Hiromichi Ito, Kentaro Inamura. Schistosoma japonicum-related hepatitis: potential contributor to hepatocellular carcinoma. QJM : monthly journal of the Association of Physicians. 2024
Yasuyuki Shigematsu, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Kentaro Inamura. Relationships between CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma. 2024

ｍore...

MISC (187)：

亜森グランバル, 重松康之, 菅原江美子, 竹内賢吾, 稲村健太郎, 公益財団法人がん研究会がん研究所分子標的病理プロジェクト. 腎がんにおけるB7-H3発現と免疫環境. 日本病理学会会誌. 2022. 111. 1. 223-223
菅原江美子, 亜森グランバル, 重松康之, 竹内賢吾, 稲村健太郎, がん研究所・分子標的病理プロジェクト. 淡明細胞型腎細胞癌におけるCDH6発現の臨床病理学的意義. 日本病理学会会誌. 2022. 111. 1. 223-223
松原修, 二宮浩範, 稲村健太郎, 神靖人. 細気管支周囲化生(ランベルトシス、Peribronchiolar metaplasia: PBM)の病理学的意義の再評価. 日本病理学会会誌. 2022. 111. 1. 241-241
宇根みなみ, 竹村公佑, 伊藤将也, 小林秀一郎, 稲村健太郎, 湯浅健, 米瀬淳二, 古賀文隆. ドセタキセル治療を受けた転移性去勢抵抗性前立腺癌患者における血清γ-グルタミルトランスフェラーゼの予後的意義(Prognostic significance of serum gamma-glutamyltransferase in patients with metastatic castration-resistant prostate cancer treated with docetaxel). 日本泌尿器科学会総会. 2021. 109回. ISP02-06
中島康裕, 二宮浩範, 稲村健太郎, 小林正嗣, 石橋洋則, 桐村進, 阪井宏彰, 山本鉄郎, 大久保憲一, 石川雄一. 中皮腫における癌幹細胞マーカーの発現と臨床・病理組織学的検討. 肺癌. 2021. 61. 6. 665-665

ｍore...

Education (2)：

Professional career (1)：

Work history (8)：

2024/04 - 現在 Jichi Medical University Division of Tumor Pathology Professor
2020/01 - 2024/03 The Cancer Institute, Japanese Foundation for Cancer Research Division of Pathology Senior Staff Scientist
2015/04 - 2019/12 The Cancer Institute, Japanese Foundation for Cancer Research Division of Pathology Staff Scientist
2014/04 - 2015/03 Dana-Farber Cancer Institute / Harvard Medical School Postdoctoral Fellow
2012/04 - 2014/03 National Cancer Institute, National Institutes of Health, USA

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page